 WATERTOWN, Mass., Feb. 18, 2021 GLOBE NEWSWIRE -- Pandion Therapeutics, Inc. Nasdaq: PAND, a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases, today announced that Rahul Kakkar, M.D., Chief Executive Officer of Pandion Therapeutics, will present at the upcoming 10th Annual SVB Leerink Healthcare Conference on Thursday, February 25, 2021, at 9:20 a.m. ET. 